US · Healthcare · Medical Distribution
| Fund | Stake |
|---|---|
| Renaissance Technologies Corp | 0.01% |
| Northern Trust Corp | 0.01% |
| Citadel Advisors Llc | 0.01% |
| SmartHarvest Portfolios, LLC | 0.01% |
| Jane Street Group LLC | 0.00% |
| Geode Capital Management, LLC | 0.00% |
| BlackRock Inc | 0.00% |
| UBS Group AG | 0.00% |
| Document | Date |
|---|---|
| Annual report FY2026 (20-F) HEADLINE NUMBERS • Fiscal year ended March 31, 2026; the filing uses U.S. GAAP and reports in U.S. dollars. • Outstanding shares at March 31, 2026: | 2026-07-23 |
| Report of foreign private issuer (6-K) · Q1 FY2027 AUDITOR CHANGE • On May 12, 2026, Akso Health Group’s audit committee dismissed Onestop Assurance PAC as independent registered public accounting fir | 2026-05-13 |
| Report of foreign private issuer (6-K) · Q4 FY2026 HEADLINE NUMBERS • Akso Health Group offered Jianqiang Xu a position on its Board of Directors on March 20, 2026. • Board compensation is $12,000 pe | 2026-03-23 |
| Quarterly results (6-K) · Q2 FY2026 HEADLINE NUMBERS • Six-month net revenue was $6,998,646, compared with $6,934,191 in the prior-year period, an increase of approximately 0.9%. • Gro | 2026-02-10 |
| Annual report FY2025 (20-F) | 2025-08-14 |
| Report of foreign private issuer (6-K) · Q1 FY2026 | 2025-05-01 |
| Annual report FY2024 (20-F) | 2024-07-30 |
| Annual report FY2023 (20-F) | 2023-07-14 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Akso Health Group ADR — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.